RE: $1bn annual sales potential26 Jan 2025 16:24
It's the start of the journey..could be faiway to go..and I'm sure Dan will want to be involved with this until real data can command true value.
IPOs are always over inflated broker ratings
Plus the BioTech markets have been annihilated these past years.. generally because of funding needed and the rise in percentages of failed trials..
Imo if the partner in discussions likes what they see a licence deal will secure funding to get this into clinical trials.
With nfx securing a percentage of royalties on future deals.
True value won't be sought anywhere near at this point in time.
Its just traders blowing things out of proportions on expected revenue pitches.
What it would mean for nfx going forward is funding secured for next phase of trials and life being brought back to the SP.
Hope Dan can pull this off
Its good to see his and other directors commitment.
The only thing that puzzles me here is why everything is being left to last minute and why the lack of interest before.